SCHEMBL2393831

SCHEMBL2393831

COC(=O)N(C1c2ccccc2-c2ccccc21)C1(C(=O)NC2(c3ccccn3)CC2)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.40
TSHR P16473 3/20 0.37
ALOX15 P16050 1/20 0.37
ATM Q13315 1/20 0.37
CNR2 P34972 1/20 0.37
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
NAMPT P43490 1/20 0.36
USP30 Q70CQ3 1/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP2C19 P33261 1/20 0.36
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MMP13 P45452 1/20 0.35
SMO Q99835 1/20 0.34
GRM5 P41594 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18918200 0.81 TSHR (0.42) GPR119TSHRALOX15ATMUSP30
SCHEMBL2392925 0.78 GPR119 (0.46) GPR119TSHRALOX15ATMJAK2
SCHEMBL2393834 0.77 BACE1 (0.41) GPR119TSHRALOX15ATMCNR2
SCHEMBL5874127 0.71 GPR119 (0.44) GPR119TSHRALOX15ATMJAK2
SCHEMBL5472913 0.70 GPR119 (0.52) GPR119TSHRALOX15ATMJAK2
SCHEMBL5874035 0.70 GPR119 (0.45) GPR119TSHRALOX15ATMJAK2
SCHEMBL1181843 0.70 GPR119 (0.54) GPR119TSHRALOX15ATMJAK2
SCHEMBL29775911 0.69 USP30 (0.46) GPR119USP30ALDH1A1SMO
SCHEMBL6111713 0.69 CYP3A4 (0.36) TSHRCYP3A4CYP2D6HSD17B10CYP2C19
SCHEMBL6888743 0.69 GPR119 (0.53) GPR119TSHRALOX15ATMJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225238-B1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZOÝ1,2- ¨IMIDAZOLE-3- CARBOXYLIC ACID AMIDES BOEHRINGER INGELHEIM INT (DE) 2014-09-03 EP disclosed
US-8552205-B2 Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-08 US disclosed
US-20110224188-A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-09-15 US disclosed
EP-2225238-A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZOÝ1,2- ¨IMIDAZOLE-3- CARBOXYLIC ACID AMIDES Boehringer Ingelheim International GmbH (DE) 2010-09-08 EP disclosed
WO-2009070485-A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224188-A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES HPGDS, COL14A1, ARG1 GPR119 1770/4885TSHR 4087/4885ALOX15 1922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.